You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

173 Results
Guidelines and Advice
Jul 2022
Guidelines and Advice
Guidelines and Advice
Guidelines and Advice
Guidelines and Advice
Status: Current
ID: GL-C50-20
May 2015
Drug
Other Name(s): Neulasta® , Lapelga™ , Fulphila™ , Ziextenzo® , Nyvepria™
Dec 2022
Drug
Other Name(s): Femara®
May 2022

Pages